This website uses cookies to improve your experience. Learn more about cookies and how to manage them.
The programme will be based on a series of focussed, disease-based sessions that will include invited speakers, selected oral abstracts and panel discussions.
Abstracts deadline: 29 Feb 2020
Registration deadline:
BMA Great Hall, London, UK - View map
The aims of the conference are:
• Assemble leading preclinical scientists, clinical researchers, national regulators (MHRA andNICE), government bodies and cannabis-based medicinal products (CBMP) pharmaceuticalsuppliers together to align research strategies.
• Grow and stimulate CBMP pharmaceutical industry in the UK.
• Identify the implementation challenges for CBMPs clinical research.
• Educate healthcare professions. Register here